Long-term outcomes of microvascular decompression vs neurotomy for glossopharyngeal neuralgia: a multicenter clinimetric study
José D. Carrillo-Ruiz, Carlos Barzallo-Sacoto, Álvaro Diego Rivera-Arroyo, Noé Pérez-Carrillo, Abel Olivares-Quezada, Naomi Contreras-Galván, Miguel Jiménez-Olvera, Francisco Velasco-Campos, Fiacro Jiménez-Ponce, José L. Navarro-Olvera, Jesús Q. Beltrán, Gustavo Aguado CarrilloAbstract
Introduction:
Glossopharyngeal neuralgia (GPN) is a rare cranial pain syndrome, with limited comparative long-term evidence for microvascular decompression (MVD) and neurotomy (NT).
Objectives:
To compare clinimetric outcomes of microvascular decompression (MVD) and neurotomy (NT) in patients with glossopharyngeal neuralgia (GPN).
Methods:
Analytical ambispective multicenter study (1990–2024) including patients with GPN treated with MVD or NT across 3 international neurosurgical centers. Pharmacological treatment history was recorded. Pain intensity was assessed pre- and postoperatively using the Visual Analog Scale (VAS) and Barrow Neurological Institute-Pain Intensity Score. Positive sensory symptoms (PSS) including allodynia, dysesthesia, and paresthesia were evaluated when data were available.
Results:
From a total of 93 medical records, 25 patients underwent surgery; 23 met inclusion criteria (MVD = 12, NT = 11) and were evaluated long-term. Patients had a mean age of 58.48 ± 14.33 years, and follow-up ranged from 6 months to 14 years (mean 5.2 ± 4.52). All patients were refractory to pharmacotherapy. Overall VAS scores decreased from 4 to 10 (mode 10) preoperatively to 0 to 5 (mode 0) postoperatively (
Conclusions:
Both MVD and NT are highly effective in reducing pain and PSS in GPN, with comparable postoperative outcomes. Limitations include small sample size and ambispective design.